Human Fibrinogen Concentrate in Pediatric Cardiac Surgery

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The goal of the study is to determine whether the use of Human Fibrinogen Concentrate (RiaSTAP) will decrease blood loss and the need for component blood therapy in neonates and infants undergoing cardiopulmonary bypass.
Epistemonikos ID: 9bd04fcc16c3da21224cf4b163320d622a114724
First added on: May 17, 2024